Literature DB >> 31169570

An overview of reactive arthritis.

Megan Pennisi1, Jacqueline Perdue, Tessa Roulston, Joyce Nicholas, Eric Schmidt, Jenna Rolfs.   

Abstract

Reactive arthritis, also known as Reiter syndrome, is a spondyloarthropathy that typically follows a urogenital or gastrointestinal infection, and is characterized by conjunctivitis, urethritis, and arthritis. The frequency of reactive arthritis in the United States is estimated at 3.5 to 5 patients per 100,000. Physician assistants (PAs) can manage the condition; therefore, they should be familiar with the disease's signs and symptoms, diagnostic criteria, and treatment regimens. Without proper management, reactive arthritis can progress to a chronic destructive arthritis. Prompt recognition of the condition is key to early intervention and a better patient outcome with fewer complications.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31169570     DOI: 10.1097/01.JAA.0000558320.47868.2f

Source DB:  PubMed          Journal:  JAAPA        ISSN: 0893-7400


  4 in total

Review 1.  Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens.

Authors:  Henning Zeidler; Alan P Hudson
Journal:  Curr Rheumatol Rep       Date:  2021-07-01       Impact factor: 4.592

Review 2.  Reactive Arthritis: Update.

Authors:  Ibtissam Bentaleb; Kawther Ben Abdelghani; Samira Rostom; Bouchra Amine; Ahmed Laatar; Rachid Bahiri
Journal:  Curr Clin Microbiol Rep       Date:  2020-09-26

3.  Reactive arthritis and silent thyroiditis following SARS-CoV-2 infection: Case report and review of the literature.

Authors:  Jacob Quaytman; Usha Gollamudi; Noah Bass; Shashank Suresh
Journal:  Clin Case Rep       Date:  2022-02-07

4.  Reactive Arthritis After Intravesical Bacillus Calmette-Guérin Therapy.

Authors:  Yoshinori Taniguchi; Hirofumi Nishikawa; Takahito Kimata; Yasuhiko Yoshinaga; Shigeto Kobayashi; Yoshio Terada
Journal:  J Clin Rheumatol       Date:  2022-03-01       Impact factor: 3.902

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.